GuruTrack
MRSH

MRSH

MARSH & MCLENNAN COS

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary
MARSH & MCLENNAN COS (MRSH) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$92.33M; the largest are Ken Griffin, Joel Greenblatt, Paul Tudor Jones. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 2 new, 1 added, 2 trimmed, 1 closed. 20 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders52 also report options
Congress trades20
Price$169.03vs quarter-end+1.42%
Sectors0
This quarter's moves
New2
Added1
Trimmed / sold3
Top holderKen Griffin

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Value $23.83M— of portfolio143,0002026 Q2
Value $983.4K— of portfolio5,9002026 Q2
Value $783.3K— of portfolio4,7002026 Q2

Insider Trading

Officers · directors · Form 4
Open-market purchases and sales (P/S)5
  • John Jude Jones

    Chief Marketing Officer

    Sell$1.25M
    6,500 @ $191.96Traded 2026-08-06Filed 2026-08-07
  • Paul Beswick

    SVP, Chief Information Officer

    Sell$141.2K
    713 @ $198.00Traded 2026-07-29Filed 2026-07-31
  • Martin South

    Chief Client Officer

    Sell$1.35M
    7,100 @ $189.99Traded 2026-07-28Filed 2026-07-29
  • Lloyd M Yates

    Director

    Sell$2.11M
    12,000 @ $175.65Traded 2026-07-23Filed 2026-07-24
  • John Q Doyle

    President and CEO

    Sell$2.69M
    16,656 @ $161.71Traded 2026-06-02Filed 2026-06-03

Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.